Cormedix (HAM:19KA) Cyclically Adjusted Book per Share: €1.52 (As of Mar. 2026)


HAM:19KA Cormedix Inc HAM:19KA
43 GF Score
Price €7.43
GF Value €51.37
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Cormedix Cyclically Adjusted Book per Share?

Cormedix HAM:19KA +12.88% 43 Cyclically Adjusted Book per Share is €1.52 as of Mar. 2026. GuruFocus rates HAM:19KA with a GF Score™ of 43/100 and a GF Value™ of €51.37 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cormedix's adjusted book value per share for the three months ended in Mar. 2026 was €4.822. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.52 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cormedix's average Cyclically Adjusted Book Growth Rate was -7.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cormedix was 16.10% per year. The lowest was -0.50% per year. And the median was 5.60% per year.

As of today (2026-07-03), Cormedix's current stock price is €7.434. Cormedix's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €1.52. Cormedix's Cyclically Adjusted PB Ratio of today is 4.89.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cormedix was 15.29. The lowest was 1.73. And the median was 4.12.


Cormedix  (HAM:19KA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cormedix's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=7.434/1.52
=4.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cormedix was 15.29. The lowest was 1.73. And the median was 4.12.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cormedix Cyclically Adjusted Book per Share Related Terms


Cormedix Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cormedix's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cormedix Cyclically Adjusted Book per Share Chart

Cormedix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.65

Cormedix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 1.65 1.52

HAM:19KA vs STTK, ACHV, EIKN: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Cormedix's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cormedix Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cormedix's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cormedix's Cyclically Adjusted PB Ratio falls into.


HAM:19KA
43GF Score
Cormedix Inc HAM:19KA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cormedix Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cormedix's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.822/330.2130*330.2130
=4.822

Current CPI (Mar. 2026) = 330.2130.

Cormedix Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.349 241.018 4.588
201609 2.622 241.428 3.586
201612 2.089 241.432 2.857
201703 1.268 243.801 1.717
201706 1.152 244.955 1.553
201709 0.655 246.819 0.876
201712 0.426 246.524 0.571
201803 0.042 249.554 0.056
201806 -0.326 251.989 -0.427
201809 -0.412 252.439 -0.539
201812 0.199 251.233 0.262
201903 0.615 254.202 0.799
201906 0.612 256.143 0.789
201909 1.016 256.759 1.307
201912 0.829 256.974 1.065
202003 0.748 258.115 0.957
202006 0.630 257.797 0.807
202009 0.934 260.280 1.185
202012 1.083 260.474 1.373
202103 1.773 264.877 2.210
202106 1.675 271.696 2.036
202109 1.548 274.310 1.863
202112 1.459 278.802 1.728
202203 1.404 287.504 1.613
202206 1.421 296.311 1.584
202209 1.380 296.808 1.535
202212 1.214 296.797 1.351
202303 1.132 301.836 1.238
202306 0.988 305.109 1.069
202309 1.422 307.789 1.526
202312 1.171 306.746 1.261
202403 0.971 312.332 1.027
202406 0.776 314.175 0.816
202409 0.914 315.301 0.957
202412 1.255 315.605 1.313
202503 1.569 319.799 1.620
202506 2.563 322.561 2.624
202509 4.068 324.800 4.136
202512 4.367 324.054 4.450
202603 4.822 330.213 4.822

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €1.52 mean?
Cormedix (HAM:19KA) has a Cyclically Adjusted Book per Share of €1.52 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cormedix and its competitors.
Is Cormedix's Cyclically Adjusted Book per Share too high?
Cormedix's current Cyclically Adjusted Book per Share is €1.52. Overall, Cormedix has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cormedix's Cyclically Adjusted Book per Share compare to STTK and ACHV?
Cormedix's Cyclically Adjusted Book per Share of €1.52 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cormedix and its competitors. Cormedix's current Cyclically Adjusted Book per Share is €1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cormedix stock overvalued right now?
Based on GuruFocus' analysis, Cormedix (HAM:19KA) is currently considered Possible Value Trap. The stock's GF Value™ is €51.37, compared to a current price of €7.43 — trading 85.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is €1.52. Cormedix's overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cormedix (HAM:19KA), the current Cyclically Adjusted Book per Share is €1.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cormedix (HAM:19KA) Overvalued in 2026?

Based on GuruFocus' analysis, Cormedix stock appears to be undervalued. The current stock price of €7.43 is trading 85.5% below its estimated GF Value™ of €51.37. GuruFocus considers Cormedix to be Possible Value Trap.

Key valuation signals for HAM:19KA:

  • Cyclically Adjusted Book per Share: €1.52
  • GF Value™: €51.37 vs. price of €7.43 (85.5% below fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the HAM:19KA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cormedix Business Description

Other Exchanges CRMD:USA19KA:Germany
Address 389 Interpace Parkway, Suite 450, Parsippany, NJ, USA, 07054
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
43GF Score

Get the complete analysis for HAM:19KA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.43
Price
€51.37
GF Value